AGENUS INC AGEN Income Statement

Agenus inc (AGEN)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue:
Total revenues
85,285	150,048	121,997	114,859	115,039	36,784	33,692	25,097	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Grant revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Service revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	1,417	2,111	2,240	2,156	1,489	0	0	0	-	-	-	-	-	-
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	24,464	26,866	26,651	24,792	18,293	13,008	9,705	6,473	5,735	4,551	1,964	1,627	1,631	1,634	1,538	14,470	14,742	15,147	0	-	0	0	-	0	0
Revenue (research and development)
-	-	-	-	-	-	-	-	-	-	-	-	43,570	-	24,636	27,038	26,822	24,817	18,797	13,512	10,209	6,977	5,750	4,923	2,656	3,045	3,742	3,875	3,695	15,960	15,514	15,299	15,458	2,755	2,736	2,887	0	0	0
Operating expenses:
Cost of service revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	536	1,570	1,273	968	671	0	0	0	-	-	-	0	0	0
Research and development
164,572	168,339	167,536	151,258	135,289	124,600	120,440	116,375	112,926	116,125	110,236	106,035	102,572	94,971	86,937	83,851	86,262	70,444	59,864	46,647	27,096	22,349	18,221	16,829	14,923	13,005	28,521	22,023	15,795	10,564	-5,338	-204	5,530	11,022	10,988	11,090	0	0	0
General and administrative
45,849	46,041	43,446	41,137	39,217	37,340	37,400	36,248	34,899	33,741	32,626	32,682	31,663	33,125	32,915	31,216	32,114	28,370	24,950	23,462	21,573	21,249	19,582	18,240	16,755	14,483	31,395	25,231	17,230	11,465	-6,109	-955	5,067	10,820	10,734	10,934	0	0	0
Contingent purchase price consideration fair value adjustment
1,327	-5,805	-1,301	-2,902	3,603	1,335	4,767	3,403	-2,024	3,188	9,278	-513	-2,099	-1,953	-10,731	7,238	1,176	-6,703	-6,357	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contingent purchase price consideration fair value adjustment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Operating (loss) income
-123,809	-70,137	-90,286	-80,438	-55,864	-123,821	-114,387	-119,976	-132,292	-103,801	-93,485	-98,045	-92,765	-107,476	-105,947	-80,791	-90,378	-80,700	-79,880	-76,484	-51,788	-43,320	-32,223	-31,366	-30,195	-24,980	-22,980	-20,707	-19,150	-6,740	-7,433	-7,333	-6,263	-19,086	-19,051	-19,259	0	0	0
Other expense:
Loss on modification of debt
0	-	-	-	-	-10,767	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-operating (expense) income
-1,394	28	-943	-1,364	-2,848	-2,183	-1,430	-1,785	2,271	1,977	40	373	-1,785	-2,202	1,062	548	-5,592	-5,968	-15,709	-15,183	-7,779	2,096	11,253	11,223	7,146	-2,672	-3,476	-3,316	5	110	113	110	102	1	403	1,284	0	0	0
Interest expense, net
-46,343	-41,451	-38,328	-35,208	-31,635	-25,273	-21,645	-18,812	-17,063	-18,868	-18,335	-18,040	-17,769	-17,316	-16,981	-13,972	-10,334	-6,599	-2,673	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (loss) income
-174,266	-111,560	-129,557	-117,010	-90,347	-162,044	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	10,244	8,706	7,063	4,694	-2,362	-78	2,121	4,210	4,314	4,436	0	0	0
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net loss
-	-	-	-	-	-	-	-	-	-	-111,781	-115,713	-112,319	-	-116,478	-88,827	-100,918	-87,881	-98,252	-93,239	-60,870	-42,486	-22,285	-21,494	-24,595	-30,072	-29,735	-28,146	-23,927	-11,324	-11,905	-11,710	-10,544	-23,276	-22,963	-22,400	0	0	0
Dividends on Series A-1 convertible preferred stock
208	208	207	207	207	207	207	207	206	206	205	204	204	204	203	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: net loss attributable to non-controlling interest
-3,429	-3,903	-4,200	-4,002	-3,302	-2,352	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends on Series A-1 convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	204	203	203	3,159	4,493	4,244	3,996	791	-395	0	395	790	0	0	0	-	-
Dividends on series A convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Net (loss) income attributable to Agenus Inc. common stockholders
-171,045	-107,865	-125,564	-113,215	-87,252	-159,899	-147,179	-150,895	-157,936	-120,898	-111,986	-115,917	-112,524	-127,199	-116,682	-89,031	-101,121	-88,084	-98,455	-93,442	-61,073	-42,690	-22,489	-21,698	-24,798	-33,232	-33,043	-31,600	-27,528	-12,116	-12,695	-12,500	-11,335	-24,066	-23,753	-23,191	0	0	0
Per common share data:
Basic and diluted net loss attributable to Agenus Inc. common stockholders
-	-	-0.33	-0.38	-	-	-0.29	-0.24	-	-0.36	-0.37	-0.32	-0.18	-0.29	-0.47	-0.33	-0.37	-0.16	-0.16	-0.53	-0.28	-	-0.13	-	-	-	-	-	-	-	-	-	-	-	-0.28	-0.31	-	-0.36	-0.05
Basic net (loss) income attributable to Agenus Inc. common stockholders
-0.31	-	-	-	0.14	-	-	-	-0.53	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.13	-0.01	-	-0.24	-0.40	-0.35	-	-0.24	-0.31	0.29	-	-	-	-0.33	-	-
Comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-25,187	-26,926	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Other Comprehensive Income (Loss), Tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Diluted net (loss) income attributable to Agenus Inc. common stockholders
-0.31	-	-	-	0.12	-	-	-	-0.53	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.29	-	-	-	-0.33	-	-
Weighted average number of Agenus Inc. common shares outstanding:
Basic
145	-	-	-	129	-	-	-	102	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,335	-	-	-	18,811	-	-
Diluted
145	-	-	-	148	-	-	-	102	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,337	-	-	-	18,811	-	-
Basic and diluted
-	-	137,619	134,636	-	-	114,977	105,113	-	-292,208	99,891	99,201	93,508	87,422	87,206	86,964	86,686	85,237	84,569	76,374	66,667	-	62,831	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive (loss) income:
Basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	62,607	50,556	-	30,345	27,845	25,071	-	24,529	22,947	-	-	20,225	19,004	-	-	-
Foreign currency translation (loss) gain
2,124	215	332	498	485	630	468	737	-1,020	-615	-345	-478	6	677	33	-746	-60	164	7	-605	-1,229	-1,778	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Unrealized loss on investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive (loss) income
2,124	215	332	498	485	630	443	712	-1,045	-640	-499	-631	-146	523	-227	-999	-308	-82	-174	-794	-1,421	-1,970	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-
Comprehensive (loss) income
-168,921	-107,650	-125,232	-112,717	-86,767	-159,269	-146,735	-150,182	-158,981	-121,538	-112,485	-116,549	-112,671	-126,675	-114,377	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of common shares outstanding, basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,516	95,754
Research and Development [Member]
Total revenues
30,902	99,845	82,111	82,636	88,710	19,475	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Revenue [Member]
Total revenues
4,308	4,679	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-Cash Royalty Revenue Related to the Sale of Future Royalties [Member]
Total revenues
0	-	36,598	29,816	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-